Emerald Advisers LLC boosted its holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) by 39.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 836,909 shares of the company’s stock after purchasing an additional 235,683 shares during the quarter. Amylyx Pharmaceuticals […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares shot up 4.7% during trading on Thursday . The stock traded as high as $29.45 and last traded at $29.12. 365,256 shares were traded during trading, a decline of 61% from the average session volume of 930,485 shares. The stock had previously closed at $27.81. Analysts Set […]
Mizuho began coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) in a report released on Thursday, The Fly reports. The firm issued a buy rating and a $52.00 target price on the stock. Several other analysts also recently weighed in on AMLX. HC Wainwright reissued a buy rating and issued a $50.00 target […]